Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S10 pseudogene 14 (RPS10P14) is a processed pseudogene corresponding to the ribosomal protein S10 gene. Unlike its parental gene, RPS10, which encodes a component of the 40S ribosomal subunit essential in protein synthesis, RPS10P14 accumulates mutations or truncations and does not encode a functional protein. Pseudogenes such as RPS10P14 are generally not transcribed or translated and have no direct biological or pathological roles. There is no evidence supporting its use as a therapeutic target or biomarker, and it is not associated with drug interactions or safety concerns. The gene is referenced in databases solely as a genomic locus of potential research interest rather than a functional or disease-related sequence.
There is no known mechanism of action for drugs targeting RPS10P14, as it is not an expressed or functional gene product.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S10 pseudogene 14 (RPS10P14).